CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 36,687 shares (to pay taxes)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 46,777 shares (to pay taxes)
- EFFECT Other Notice of Effectiveness
- 8-K Event Results of operations · Other events
- 4 Grant or award CFO acquired 125,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award CEO acquired 250,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Accounting Officer acquired 62,500 shares (grant or award)
Page 2 of 19 · 362 filings